Pharmaceutical Company Seeks to Capitalize on Trend of ‘Ozempic Face’ with Cosmetic Fillers

Capitalizing on the ‘Ozempic Face’ Phenomenon: Galderma’s Growing Innovation in Skin Care Treatments

Galderma, a Swiss pharmaceutical company known for its innovative skin care treatments, has identified an opportunity in the “Ozempic face” phenomenon. The CEO believes that the growing popularity of weight-loss drugs like Ozempic could lead to an increase in demand for their facial fillers products. This is because Ozempic can cause a sunken-in look in some patients’ faces, which fillers can help to counteract.

Galderma has been developing products like Sculptra and Restylane to address the aesthetic concerns associated with Ozempic face. Sculptra is designed to restore the gaunt look associated with rapid weight loss, while Restylane helps to enhance cheek contours. The company has started a study to evaluate the effects of these products on patients using GLP-1 treatments, and enrollment is ongoing. Results are expected by the end of the year.

The term “Ozempic face” has become increasingly common in dermatology practices due to the widespread use of weight-loss medications. It refers to the sunken and aged appearance that can result from rapid weight loss. Dermatologists have noted that this condition often requires cosmetic intervention, such as facial fillers, to restore a more youthful appearance.

Galderma’s recent IPO on the SIX Swiss Exchange was met with positive reception by investors, and sales for the first quarter were up 12.4% year-over-year compared to last year’s results. The company also owns popular drug store brand Cetaphil, which further strengthens its position in the marketplace. The CEO remains optimistic about the growth potential in the fillers market and plans to capitalize on this trend by developing new products and expanding its customer base.

In conclusion, Galderma sees an opportunity in targeting patients who experience “Ozempic face” after using weight loss drugs like Ozempic by offering facial filler treatments such as Sculptra and Restylane that will help them regain their natural beauty and confidence.

Leave a Reply

Robert Fico aims to control the state media. Previous post Slovak Government Targets Media Freedom: A Look at the Battle for Press Freedom in Eastern Europe
Egypt introduces new customs facilities to streamline food imports Next post Egyptian Government to Implement New Measures to Control Food Prices in the Market